EE04811B1 - Asendatud 3-fenüül-5-alkoksü-1,3,4-oksdiasool-2-oon, selle valmistamine ja kasutamine lipaasi inhibiitorina ning seda sisaldav ravim - Google Patents

Asendatud 3-fenüül-5-alkoksü-1,3,4-oksdiasool-2-oon, selle valmistamine ja kasutamine lipaasi inhibiitorina ning seda sisaldav ravim

Info

Publication number
EE04811B1
EE04811B1 EEP200200109A EEP200200109A EE04811B1 EE 04811 B1 EE04811 B1 EE 04811B1 EE P200200109 A EEP200200109 A EE P200200109A EE P200200109 A EEP200200109 A EE P200200109A EE 04811 B1 EE04811 B1 EE 04811B1
Authority
EE
Estonia
Prior art keywords
oxydiazol
alkoxy
phenyl
substituted
preparation
Prior art date
Application number
EEP200200109A
Other languages
English (en)
Estonian (et)
Inventor
Petry Stefan
Schoenafinger Karl
Mueller Guenter
Baringhaus Karl-Heinz
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of EE200200109A publication Critical patent/EE200200109A/xx
Publication of EE04811B1 publication Critical patent/EE04811B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EEP200200109A 1999-09-04 2000-08-22 Asendatud 3-fenüül-5-alkoksü-1,3,4-oksdiasool-2-oon, selle valmistamine ja kasutamine lipaasi inhibiitorina ning seda sisaldav ravim EE04811B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19942354A DE19942354A1 (de) 1999-09-04 1999-09-04 Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
PCT/EP2000/008150 WO2001017981A1 (de) 1999-09-04 2000-08-22 Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one und ihre verwendung als lipase-hemmer

Publications (2)

Publication Number Publication Date
EE200200109A EE200200109A (et) 2003-06-16
EE04811B1 true EE04811B1 (et) 2007-04-16

Family

ID=7920884

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200109A EE04811B1 (et) 1999-09-04 2000-08-22 Asendatud 3-fenüül-5-alkoksü-1,3,4-oksdiasool-2-oon, selle valmistamine ja kasutamine lipaasi inhibiitorina ning seda sisaldav ravim

Country Status (30)

Country Link
US (1) US6596742B1 (pl)
EP (1) EP1214302B1 (pl)
JP (1) JP2003508522A (pl)
KR (1) KR100723817B1 (pl)
CN (1) CN1152024C (pl)
AR (1) AR032430A1 (pl)
AT (1) ATE253059T1 (pl)
AU (1) AU781330B2 (pl)
BR (1) BR0013765A (pl)
CA (1) CA2383731A1 (pl)
CZ (1) CZ2002772A3 (pl)
DE (2) DE19942354A1 (pl)
DK (1) DK1214302T3 (pl)
EE (1) EE04811B1 (pl)
ES (1) ES2204685T3 (pl)
HK (1) HK1048318B (pl)
HR (1) HRP20020187A2 (pl)
HU (1) HUP0202988A3 (pl)
IL (2) IL148275A0 (pl)
MX (1) MXPA02001834A (pl)
NO (1) NO323129B1 (pl)
NZ (1) NZ517551A (pl)
PL (1) PL197314B1 (pl)
PT (1) PT1214302E (pl)
RU (1) RU2265600C2 (pl)
SK (1) SK285924B6 (pl)
TR (1) TR200200553T2 (pl)
WO (1) WO2001017981A1 (pl)
YU (1) YU10402A (pl)
ZA (1) ZA200201594B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10102265C1 (de) * 2001-01-18 2002-08-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneistoffen
US6900233B2 (en) 2002-02-28 2005-05-31 Aventis Pharma Deutschland Gmbh Substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadiazol-2-ones, pharmaceutical composition and method for treating obesity thereof
DE10208987A1 (de) * 2002-02-28 2003-09-11 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxidiazol-2-one, ihre Herstellung und Verwendung in Arzneistoffen
DE10208986A1 (de) * 2002-02-28 2003-09-11 Aventis Pharma Gmbh Verwendung substituierter 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one zur Herstellung von Arzneimitteln mit hemmender Wirkung an der pankreatischen Lipase
DE10247680B4 (de) * 2002-10-12 2005-09-01 Aventis Pharma Deutschland Gmbh Neue bicyclische Inhibitoren der Hormon Sensitiven Lipase
US7208504B2 (en) 2002-10-12 2007-04-24 Sanofi-Aventis Deutschland Gmbh Bicyclic inhibitors of hormone sensitive lipase
KR20070084067A (ko) * 2004-10-13 2007-08-24 와이어쓰 Ｎ-벤젠설포닐 치환 아닐리노-피리미딘 동족체
CN101821227A (zh) * 2007-07-12 2010-09-01 德维里斯公司 激素敏感性脂酶调节剂及使用方法
WO2009084970A1 (en) * 2007-12-27 2009-07-09 Bial-Portela & Companhia, S.A. 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use
TW201028406A (en) 2008-12-23 2010-08-01 Bial Portela & Ca Sa 5-O-substituted 3-N-aryl-1,3,4-oxadiazolones for medical use
US8501768B2 (en) * 2011-05-17 2013-08-06 Hoffmann-La Roche Inc. Hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds
CN114163351B (zh) * 2020-09-11 2024-01-23 江苏优嘉植物保护有限公司 噁虫酮中间体2-(2-甲氧基)苯肼甲酸甲酯合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB518042A (en) 1937-09-15 1940-02-15 Ljungstroms Angturbin Ab Improvements in elastic fluid turbines of the double rotation type
US4076824A (en) 1975-02-03 1978-02-28 Rhone-Poulenc Industries Anthelmintic oxadiazolinone derivatives
FR2299028A1 (fr) 1975-02-03 1976-08-27 Rhone Poulenc Ind Nouvea
FR2299328A1 (fr) 1975-02-03 1976-08-27 Rhone Poulenc Ind Derives de l'alcoyloxy-5 phenyl-3 oxyde azo
DK156439C (da) 1980-09-15 1990-01-22 Shell Int Research 7-substituerede 2,3-dihydrobenzofuranderivater samt pesticidpraeparater indeholdende disse og en fremgangsmaade til bekaempelse af skadelige organismer
EP0067471B1 (en) 1981-06-15 1985-11-06 Shell Internationale Researchmaatschappij B.V. 7-substituted 2,3-dihydrobenzofurans, their preparation and their use as pesticides or as chemical intermediates
JPS60115502A (ja) * 1983-11-28 1985-06-22 Mitsubishi Chem Ind Ltd 殺虫剤
US5236939A (en) 1989-09-23 1993-08-17 Bayer Aktiengesellschaft Substituted 1,3,4-oxa(thia)diazolinones process for their preparation and their use of combating endoparasites
DE3931843A1 (de) 1989-09-23 1991-04-04 Bayer Ag Substituierte 1,3,4-oxa(thia)diazolinone verfahren zu ihrer herstellung und ihre verwendung der bekaempfung von endoparasiten
US5641796A (en) * 1994-11-01 1997-06-24 Eli Lilly And Company Oral hypoglycemic agents

Also Published As

Publication number Publication date
CN1371369A (zh) 2002-09-25
HUP0202988A3 (en) 2004-12-28
AR032430A1 (es) 2003-11-12
MXPA02001834A (es) 2002-08-12
CA2383731A1 (en) 2001-03-15
SK285924B6 (sk) 2007-11-02
EP1214302B1 (de) 2003-10-29
SK3012002A3 (en) 2002-06-04
AU781330B2 (en) 2005-05-19
IL148275A0 (en) 2002-09-12
HK1048318A1 (en) 2003-03-28
JP2003508522A (ja) 2003-03-04
US6596742B1 (en) 2003-07-22
CZ2002772A3 (cs) 2002-05-15
PL353214A1 (pl) 2003-11-03
NO20021007L (no) 2002-02-28
NZ517551A (en) 2003-10-31
ES2204685T3 (es) 2004-05-01
ATE253059T1 (de) 2003-11-15
HK1048318B (zh) 2004-12-10
KR20020024336A (ko) 2002-03-29
BR0013765A (pt) 2002-04-30
CN1152024C (zh) 2004-06-02
KR100723817B1 (ko) 2007-06-04
ZA200201594B (en) 2003-04-30
NO323129B1 (no) 2007-01-08
DE19942354A1 (de) 2001-03-08
EP1214302A1 (de) 2002-06-19
EE200200109A (et) 2003-06-16
PL197314B1 (pl) 2008-03-31
DE50004274D1 (de) 2003-12-04
PT1214302E (pt) 2004-03-31
TR200200553T2 (tr) 2002-06-21
DK1214302T3 (da) 2004-02-16
HRP20020187A2 (en) 2004-02-29
AU7411200A (en) 2001-04-10
NO20021007D0 (no) 2002-02-28
HUP0202988A2 (hu) 2002-12-28
RU2265600C2 (ru) 2005-12-10
WO2001017981A1 (de) 2001-03-15
IL148275A (en) 2008-08-07
YU10402A (sh) 2004-11-25

Similar Documents

Publication Publication Date Title
HUP0201103A3 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
EE05169B1 (et) Asendatud oksasolidinoonid ja nende kasutamine
HUP0200831A3 (en) Novel pharmaceutical composition containing amoxycillin and its use
FI991485A0 (fi) Uusi farmaseuttinen koostumus
EE05107B1 (et) Türosiinkinaasi pärssiv ühend, seda sisaldav farmatseutiline kompositsioon ning ühendi kasutamine
NO20006630L (no) Farmasöytisk sammensetning for behandlingen av diabetes
EE9700310A (et) N-propargüül-1-aminoindaani R-enantiomeeri, selle soolade ja kompositsioonide kasutamine
DK1052974T3 (da) Farmaceutisk sammensætning indeholdende epothilon
EE200000232A (et) Farmatseutiline kompositsioon ja selle kasutamine
NO20015175L (no) Farmasöytisk sammensetning
ID27667A (id) Komposisi coklat dan pemakaiannya
EP1405859A4 (en) NITROGENIC HETEROCYCLIC DERIVATIVE, MEDICAL COMPOSITION, MEDICAL USE AND INTERMEDIATE PRODUCTS CONTAINING THEREOF
HUP0204071A3 (en) Nitrogenous cyclic compounds and pharmaceutical compositions containing the same and their use
EE200200498A (et) Asendatud 3-fenüül-5-alkoksü-1,3,4-oksadiasol-2-oon, selle valmistamine ja kasutamine hormoontundlikku lipaasi pärssivas ravimis ning seda sisaldav suhkurtõve ravim
AU2000276362A1 (en) Composition for the treatment of diabetes
EE04490B1 (et) Ühend, selle valmistamise meetod ning kasutamine meditsiinis
EE200100096A (et) Asatsüklilise tüvistruktuuriga tsükliline ühend, seda sisaldav farmatseutiline kompositsioon ning selle kasutamine ravimina
EE200200109A (et) Asendatud 3-fenüül-5-alkoksü-1,3,4-oksdiasool-2-oon, selle valmistamine ja kasutamine lipaasi inhibiitorina ning seda sisaldav ravim
GB2356569B (en) Fragrance dispenser for use with the internet
NO20011490D0 (no) Sugerør av sukkertøy
EE200000099A (et) Antimükootiline kompositsioon, selle kasutamine ja valmistamismeetod ning antimükootiline toode
IL127518A0 (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
IL151197A0 (en) Thiazepinyl hydroxamic acid derivatives and pharmaceutical compositions containing the same
ATE254929T1 (de) Oralverabreichbare lösung von prucaloprid
EE04260B1 (et) Farmatseutiline kompositsioon, selle valmistamisemeetod ja kasutamine

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20090822